PSMA-T4

· Narodowe Centrum Badań Jądrowych (NCBJ) Polatom

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PSMA-T4, covering 2026-04-14 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2/3,PSMA-T4, Prostate Cancer [NA]